The National Institutes of Health (NIH) intends to award a non-competitive, firm-fixed-price purchase order to Boston University for continued integration of the NHLBI Laboratory of Hemostasis & Platelet Biology into the Framingham Heart Study (FHS). Performance of services will be located at Boston University in Boston, MA, as they are the only source with on-site wet-lab access to FHS participants, samples, and core de-identified data. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold. No specific budget amount or submission timeline is mentioned in the description. The requirement is not set aside for small business.